Search results
Showing 8731 to 8745 of 9128 results
In development Reference number: GID-TA11482 Expected publication date: TBC
In development Reference number: GID-TA11771 Expected publication date: TBC
Mozafancogene autotemcel for treating Fanconi anaemia in people 1 to 17 years [TSID12203]
In development Reference number: GID-TA11781 Expected publication date: TBC
In development Reference number: GID-TA11310 Expected publication date: TBC
In development Reference number: GID-TA11567 Expected publication date: TBC
In development Reference number: GID-TA10261 Expected publication date: TBC
In development Reference number: GID-TA11679 Expected publication date: TBC
In development Reference number: GID-TA11631 Expected publication date: TBC
Vimseltinib for treating tenosynovial giant cell tumours when surgery is unsuitable [TSID12099]
In development Reference number: GID-TA11640 Expected publication date: TBC
Netarsudil for treating open angle glaucoma or ocular hypertension [ID1078]
Technology appraisal Reference number: TA1180 Published: 16 July 2026
This guidance has been replaced by NICE guideline NG17.
Farco-fill Protect for indwelling urinary catheterisation (MIB121)
July 2021: NICE has withdrawn the medtech innovation briefing (MIB) on Farco-fill Protect for indwelling urinary catheterisation because the product has been withdrawn from the UK market.
Saving babies' hearing: how a world-first rapid genetic test is transforming neonatal care
Learn how NICE's healthtech guidance helped bring life-changing genetic testing to neonatal units across the UK, saving 20 babies' hearing so far with potential to prevent hearing loss in 200 babies annually.
First new NHS treatment in over 20 years recommended for women with resistant ovarian cancer
The treatment uses a targeted therapy that seeks out a specific protein found on the surface of cancer cells and delivers a cancer-killing medicine directly to them.
Why flexibility is built into everything we do at NICE Advice
No two products are the same, so no two NICE Advice projects should be either. Andrew Walsh explains how NICE Advice adapts its services to fit your situation.